Clover Health Investments Corp (CLOV) concluded trading on Thursday at a closing price of $3.00, with 5.35 million shares of worth about $16.04 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 191.26% during that period and on December 12, 2024 the price saw a loss of about -3.85%. Currently the company’s common shares owned by public are about 394.44M shares, out of which, 377.31M shares are available for trading.
Stock saw a price change of -12.28% in past 5 days and over the past one month there was a price change of -7.69%. Year-to-date (YTD), CLOV shares are showing a performance of 215.09% which increased to 225.45% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.61 but also hit the highest price of $4.71 during that period. The average intraday trading volume for Clover Health Investments Corp shares is 7.21 million. The stock is currently trading -9.24% below its 20-day simple moving average (SMA20), while that difference is down -18.46% for SMA50 and it goes to 46.21% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Clover Health Investments Corp (NASDAQ: CLOV) currently have 394.44M outstanding shares and institutions hold larger chunk of about 16.39% of that.
The stock has a current market capitalization of $1.50B and its 3Y-monthly beta is at 1.95. It has posted earnings per share of -$0.19 in the same period. It has a debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLOV, volatility over the week remained 4.48% while standing at 4.30% over the month.
Stock’s fiscal year EPS is expected to rise by 73.31% while it is estimated to decrease by -16.46% in next year. EPS is likely to grow at an annualized rate of 19.10% for next 5-years, compared to annual growth of -585.84% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on October 07, 2024 offering a Neutral rating for the stock and assigned a target price of $4 to it. Coverage by Cowen stated Clover Health Investments Corp (CLOV) stock as a Market perform in their note to investors on February 02, 2022, suggesting a price target of $3 for the stock. On February 02, 2022, Canaccord Genuity Initiated their recommendations, while on January 19, 2022, SVB Leerink Initiated their ratings for the stock with a price target of $3. Stock get a Neutral rating from Citigroup on January 10, 2022.
